# Inhibrx Biosciences, Inc.: Form SCHEDULE 13D/A, filed Feb 26, 2025

- Company: [Inhibrx Biosciences, Inc.](/companies/inbx.md) (CIK 2007919)
- Form: SCHEDULE 13D/A
- Filed: 2025-02-26
- Accepted by EDGAR: Feb 26, 2025, 16:16 ET
- Period: not reported
- Accession: 0002007919-25-000012
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2007919/000200791925000012/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2007919/000200791925000012/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2007919/000200791925000012/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 26, 2025.
Source: SEC EDGAR, the filing index for accession 0002007919-25-000012. Last ingested by Listed: Nov 14, 2026, 21:07 ET. No prices; not investment advice.
